Growth Metrics

Bio-Techne (TECH) Cash & Equivalents (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 21.37%
Dec 31, 2025 19.26%
Sep 30, 2025 -10.62%
Jun 30, 2025 15.30%
Mar 31, 2025 -20.77%
Dec 31, 2024 -5.33%
Sep 30, 2024 23.55%
Jun 30, 2024 8.49%
Mar 31, 2024 7.52%
Dec 31, 2023 -12.47%
Sep 30, 2023 -17.67%
Jun 30, 2023 41.87%
Mar 31, 2023 -22.71%
Dec 31, 2022 -0.35%
Sep 30, 2022 -4.24%
Jun 30, 2022 7.30%
Mar 31, 2022 -24.09%
Dec 31, 2021 7.91%
Sep 30, 2021 -1.39%
Jun 30, 2021 6.96%
Mar 31, 2021 12.45%
Dec 31, 2020 -2.29%
Sep 30, 2020 15.54%
Jun 30, 2020 -6.14%
Mar 31, 2020 41.64%
Dec 31, 2019 10.41%
Sep 30, 2019 53.33%
Jun 30, 2019 -31.83%
Mar 31, 2019 11.26%
Dec 31, 2018 -9.28%
Sep 30, 2018 -22.39%
Jun 30, 2018 40.85%
Mar 31, 2018 -28.69%
Dec 31, 2017 67.61%
Sep 30, 2017 -20.90%
Jun 30, 2017 53.09%
Mar 31, 2017 1.53%
Dec 31, 2016 -15.31%
Sep 30, 2016 8.33%
Jun 30, 2016 -2.25%
Mar 31, 2016 2.30%
Dec 31, 2015 31.52%
Sep 30, 2015 -10.43%
Jun 30, 2015 -48.77%
Mar 31, 2015 14.50%
Dec 31, 2014 -5.37%
Sep 30, 2014 -69.16%
Jun 30, 2014 157.73%
Mar 31, 2014 25.61%
Dec 31, 2013 17.35%
Sep 30, 2013 -48.80%
Jun 30, 2013 8.67%
Mar 31, 2013 5.18%
Dec 31, 2012 9.54%
Sep 30, 2012 12.11%
Jun 30, 2012 22.45%
Mar 31, 2012 17.64%
Dec 31, 2011 2.22%
Sep 30, 2011 2.09%
Jun 30, 2011 -51.07%
Mar 31, 2011 16.75%
Dec 31, 2010 18.14%
Sep 30, 2010 22.17%
Jun 30, 2010 -13.02%
Mar 31, 2010 -44.65%
Dec 31, 2009 11.90%
Sep 30, 2009 8.59%